Are Poly Medicure latest results good or bad?

Poly Medicure has reported its financial results for the quarter ending March 2025, showcasing a strong performance across several key metrics. The company achieved net sales of Rs 440.83 crore, which represents a year-on-year growth of 16.60%. This figure marks the highest quarterly sales in the last five quarters, indicating a consistent upward trend in sales performance.
The operating profit (PBDIT) for the quarter reached Rs 119.46 crore, reflecting a year-on-year growth of 23.84%. This also represents the highest operating profit recorded in the last five quarters, suggesting an enhancement in operational efficiency.

Profit before tax (PBT) was reported at Rs 98.54 crore, the highest in five quarters, with a notable year-on-year growth of 27.16%. Additionally, profit after tax (PAT) stood at Rs 91.83 crore, achieving a significant year-on-year increase of 34.33%. This robust growth in profitability has resulted in an earnings per share (EPS) of Rs 9.06, the highest recorded in the last five quarters.

Overall, Poly Medicure's financial performance for the quarter indicates a solid operational framework and a positive trajectory in its financial health. It is worth noting that the company saw an adjustment in its evaluation following this performance.